Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Daprodustat in Hepatic Impairment
NCT03223337Phase 1Completed
- Sponsor
- GSK
- Start
- Jul 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of daprodustat in anemia of chronic kidney disease (CKD-A) (4 arms), sponsored by GSK. Primary endpoints: Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinite Time, Area Under the Concentration-time Curve From Time Zero to Last Time of Quantifiable Concentration and 5 more. Started Jul 2017; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03223337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03223337.